Tishomingo Connect expands fiber network into rural Mississippi with Adtran Mosaic One
5.9.2024 14:00:00 CEST | Business Wire | Press release
News summary: Service provider required scalable fiber access technology to give more underserved customers access to reliable, high-speed internet Adtran’s Mosaic One and 10G fiber access platform enable Tishomingo Connect to scale its network rapidly and efficiently Deployment expands broadband access across rural Mississippi, supporting national efforts to close the digital divide
Adtrantoday announced that Tishomingo Connect, a subsidiary of Tishomingo County Electric Power Association (TCEPA), has deployed its Mosaic One SaaS solution to enhance rural broadband access. Leveraging Adtran’s full suite of fiber-to-the-premises and home networking technologies, Tishomingo Connect is ensuring more households and businesses can benefit from its broadband service. With Adtran’s scalable and programmable fiber access technology, the service provider can maximize its existing network investment as it expands its service area to meet the growing demand for fast and reliable internet in Northeast Mississippi. Adtran’s partner LogicomUSA is also playing a key role in the development and deployment of the new broadband network, providing technical support and ongoing NOC services.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240905594150/en/
Adtran’s technology is helping Tishomingo Connect deliver high-speed broadband to underserved regions of rural Mississippi. (Photo: Business Wire)
“Fiber broadband revitalizes communities and transforms lives by increasing economic activity and enabling access to services such as telehealth. That’s why we’re determined to extend the reach of our fiber network to ensure that more households and businesses in rural areas can enjoy the same high-quality broadband as those in other parts of the state,” said Cody Durham, CEO and GM of Tishomingo Connect. “By deploying Adtran’s fiber broadband technology and harnessing the support offered by its expert team, we’re expanding our network rapidly to give communities the connectivity they deserve. What’s more, with Mosaic One, we can deliver a more efficient, consistent and reliable service for all our members.”
Tishomingo Connect’s strategic investment in Adtran’s high-capacity fiber access platform ensures they can leverage extra capacity as data demand rises. With Adtran’s scalable XGS-PON OLTs and SDX Series optical network terminals, offering up to 10Gbit/s symmetrical data rates, network expansion is seamless and rapid. Additionally, Adtran’s SDG 800 Series service delivery gateways deliver high-speed Wi-Fi 6 performance, guaranteeing robust connectivity for an increasing number of household devices. Mosaic One further empowers Tishomingo Connect with actionable intelligence, enhancing subscriber experience and optimizing operations through a comprehensive view of customer interactions. AI-driven insights enable timely maintenance and reduce service disruptions, improving network reliability and cutting operating costs.
“Adtran is proud to be a partner of Tishomingo Connect as it continues its vital work of bringing fiber broadband to its members living in underserved regions of rural Mississippi,” commented John Scherzinger, GM of Americas sales at Adtran. “We have a deep understanding of the challenges and opportunities involved for electric utilities moving into the fiber broadband space. We also have the expertise, experience and technology to ensure these crucially important high-capacity rural networks are built in the most cost-effective way possible. With our Mosaic One and multigigabit fiber access solutions, Tishomingo has a seamless and cost-effective upgrade path to offering even more capable services in the future.”
“We support the work of electric cooperative subsidiaries like Tishomingo Connect to increase broadband connectivity in regions long overlooked by other service providers. That’s why we’re proud to offer a range of value-added services that ensure more rural subscribers can take advantage of a fast and reliable internet connection,” noted Noah Southerland, CEO of LogicomUSA. “Our technology and comprehensive support services are designed to minimize costs and time without compromising quality. This makes it easier for Tishomingo Connect to deploy and manage its broadband network, and it also means end-users benefit from high-quality connectivity they can always rely on.”
About Adtran
ADTRAN Holdings, Inc. (NASDAQ: ADTN and FSE: QH9) is the parent company of Adtran, Inc., a leading global provider of open, disaggregated networking and communications solutions that enable voice, data, video and internet communications across any network infrastructure. From the cloud edge to the subscriber edge, Adtran empowers communications service providers around the world to manage and scale services that connect people, places and things. Adtran solutions are used by service providers, private enterprises, government organizations and millions of individual users worldwide. ADTRAN Holdings, Inc. is also the largest shareholder of Adtran Networks SE, formerly ADVA Optical Networking SE. Find more at Adtran, LinkedIn and X.
Published by
ADTRAN Holdings, Inc.
www.adtran.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20240905594150/en/
Contacts
For media
For media
Gareth Spence
+44 1904 699 358
public.relations@adtran.comFor investors
Rhonda Lambert
+1 256 963 7450
investor.relations@adtran.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a
Samsung Biologics Strike: Labor Union Warns of CDMO Supply Chain Risks Following Overwhelming Vote30.3.2026 11:52:00 CEST | Press release
Union members overwhelmingly approve strike action with 95.52% voting in favor on a 95.38% turnout, clearing the final legal hurdle after mediation ceased.Union emphasizes this is a fight against structural corporate governance issues, citing unresolved allegations concerning unfair labor practices and ESG compliance risks.Management adhered to a group-level wage guideline rather than bargaining on the basis of Samsung Biologics' own performance, exposing a lack of independent bargaining authority. The Samsung Biologics Labor Union (President: Jaesung Park), representing approximately 75% of the company's total employees, announced today that its members have overwhelmingly voted in favor of a strike, with 95.52% voting in favor on a 95.38% turnout during a voting period from March 24 to March 29. Following the Incheon Regional Labor Relations Commission's decision to cease mediation, the union has now secured the legal mandate to strike. The union stressed that this strike is not mere
The Premier Jumping League (PJL) Launches with a Record-Breaking $300 Million Guaranteed Prize Pot, Defining a New Era for Showjumping30.3.2026 11:00:00 CEST | Press release
The PJL empowers riders to compete as full-time professional athletes while working towards a sustainable economic model for the sport. Backed by McCourt Global and shaped by a leadership team with decades of experience in equestrian competition, sport, and entertainment, the PJL sets a new, sustainable, and globally relevant standard for elite jumping. Sixteen teams will compete across fourteen iconic international venues throughout Europe, North America, and the Middle East when the inaugural season opens in March 2027. The Premier Jumping League (PJL) launches with a record-breaking $300 million guaranteed prize pot, defining a new era for showjumping. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330990938/en/ Photography credits: Daniel Benson for The Premier Jumping League/ Wieden+Kennedy London Backed by McCourt Global and its Executive Chairman, Frank McCourt, the PJL is a groundbreaking global competition that e
Dompé Announces First Patient Enrolled in New Study of Intranasal NGF in Cerebral Palsy30.3.2026 11:00:00 CEST | Press release
Cerebral Palsy (CP) refers to a group of permanent disorders in the development of movement and posture, which causes activity limitations, and is attributed to non-progressive disturbances that occurred in the developing fetal or infant brain.1 Nerve growth factor (NGF) is a naturally-occurring protein that supports damaged nerve cells and improves nervous system signaling, Dompé is investigating whether intranasal NGF has the potential to improve movement and neurodevelopment and address underlying brain damage in people with CP. Dompé’s intranasal NGF platform builds on the Nobel Prize-winning discovery of neurobiologist Professor Rita Levi-Montalcini and biochemist Dr. Stanley Cohen. Dompé, a leading biopharmaceutical company with operations in Italy and in the U.S., announced that the first patient has been enrolled at the Agostino Gemelli IRCCS University Hospital in Rome, Italy, in a Phase 2 investigational study of an intranasal form of Nerve Growth Factor (NGF) (Cenegermin-bkb
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom